Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

U.K. guidelines for vaccinating HIV-infected adults against bacteria are based on limited data. We compared antibody responses between 211 HIV-infected and 73 HIV-uninfected adults vaccinated with pneumococcal polysaccharide vaccine (PPV) and Haemophilus influenzae b/meningococcal C polysaccharide-tetanus toxoid glycoconjugate vaccine (Hib/MenC-TT). IgG responses to Hib/MenC-TT were not significantly different. PPV induced median IgGs >1.3 μg/mL for 10/12 serotypes among HIV-uninfected participants and 5/12 in HIV-infected participants. HIV-uninfected adults had higher post-vaccination IgGs than HIV-infected adults for 4/12 serotypes (P < 0.001). Responses did not associate with CD4 count or viral suppression. In a U.K. HIV-infected population, Hib/MenC-TT induced similar responses to HIV-uninfected adults, whereas PPV induced poor responses.

Original publication

DOI

10.1097/QAI.0000000000001054

Type

Journal article

Journal

J Acquir Immune Defic Syndr

Publication Date

01/11/2016

Volume

73

Pages

287 - 293

Keywords

AIDS-Related Opportunistic Infections, Adult, Antibodies, Bacterial, Bacterial Capsules, Female, HIV Infections, Haemophilus Vaccines, Humans, Immunization, Immunization Schedule, Male, Meningococcal Vaccines, Pneumococcal Infections, Pneumococcal Vaccines